UNSPSC 51432502: Pentopril

This classification denotes an ace inhibitor with the molecular formula C18H23NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z99269057A, chemically known as 1h-indole-1-pentanoic acid, 2-carboxy-2,3-dihydro-alpha,gamma-dimethyl-delta-oxo-, ethyl ester, (2s-(1(alphas*,gammas*),2r*))- but generally known as pentopril, which bears US NIH Compound Identifier 54938. European Medicines Agency schedules Pentopril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09702MIG.

UNSPSC 51432502 Pentopril is a Commodity code that encompasses cardiovascular and emergency-response pharmaceuticals supplied to state and local health agencies, fire departments, and pharmacy benefit programs. State and local governments purchase specific medications under this code for emergency medical services, hospital formularies, and managed pharmacy initiatives—recent solicitations show demand for branded and generic formulations of medications like labetalol, epinephrine, adenosine, and diltiazem for paramedic protocols and critical-care settings. Issuing bodies include city purchasing departments procuring on behalf of fire rescue operations, state health and human services commissions managing pharmacy benefit programs, and multistate cooperative purchasing alliances aggregating pharmaceutical demand across member jurisdictions. The mix is primarily municipal fire departments and state health agencies, with cooperative purchasing vehicles playing a significant role in bundling demand across multiple state and local members.

Recent activity spans Texas, Florida, and Minnesota. The City of Tampa's Purchasing Department posted an IFB (Bid No. 26-P-00188) on April 24, 2026, for Advanced Life Support Medications with a due date of April 8, 2026, seeking 370 units of labetalol HCI 100mg vials, 1,810 units of epinephrine 1:10,000 injections, 330 units of adenosine 6mg vials, and 1,020 units of diltiazem 25mg vials for Tampa Fire Rescue, with an estimated contract value of $40,000 and a Small Local Business Enterprise sheltered-market designation offering a 5 percent bid discount not to exceed $10,000. The Texas Health and Human Services Commission issued an RFI (HHS0017013) on April 3, 2026, to explore direct-to-manufacturer prescription programs and vendor capabilities for a Therapeutic Pharmacy Initiative, signaling future demand for pharmacy benefit contracting outside traditional PBM and GPO channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) posted an RFP (S1070000015802) due March 26, 2026, for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities in Minnesota and Oregon, requiring distribution through three authorized wholesalers with evaluation weighted heavily on price competitiveness (75 percent) and effective contract start of July 1, 2026.